|
(P1392) |
CTRP9 induziert exzentrische Hypertrophie im Rahmen pathologischer kardialer Druckbelastung |
| |
|
A. Breitbart, F. Brandes, M. Appari, O. J. Müller, H. A. Katus, M. Szaroszyk, M. Korf-Klingebiel, N. Froese, U. Schrameck, K. C. Wollert, J. Bauersachs, J. Heineke (Hannover, Heidelberg) |
|
(P1393) |
Genetic ablation of Cullin-RING ubiquitin ligase 7 results in cardiomyocyte hypertrophy and increased fractional shortening |
| |
|
F. Scheufele, S. Engelhardt, A. Sarikas (München) |
|
(P1394) |
Age-dependent effects of saturated and polyunsaturated fatty acids in adult rat cardiomyocytes |
| |
|
L. Li, A.-C. Aurich, D. Stumpp, B. Niemann, M. Buerke, S. Rohrbach (Gießen, Halle/Saale, Siegen) |
|
(P1395) |
Ranolazine acts as a β-blocker and ameliorates work-induced diastolic malfunction in a murine model of hypertrophic cardiomyopathy |
| |
|
F. Flenner, F. W. Friedrich, S. Reischmann, K. Soehren, T. Christ, T. Eschenhagen, L. Carrier (Hamburg) |
|
(P1396) |
Evidence for a role of premature senescence in cardiac fibrosis |
| |
|
K. Meyer, B. Hodwin, S. Engelhardt, A. Sarikas (München) |
|
(P1397) |
Critical Role of Fibronectin for pathological cardiac hypertrophy but not physiological growth |
| |
|
M. Konstandin, M. Völkers, S. Din, N. Gude, M. A. Sussman (Heidelberg; San Diego, US) |
|
(P1398) |
p38 MAPK protects the heart from AngiotensinII-induced cardiac remodelling |
| |
|
K. Bottermann, J. Stegbauer, S. Mende, S. Stamer, A. Gödecke (Düsseldorf) |
|
(P1399) |
Isolation of coronary smooth muscle cells, endothelial cells, fibroblasts, leukocytes and cardiomyocytes from adult infarcted mouse heart for culture and ex vivo analysis |
| |
|
L. C. Napp, S. Weisheit, P. Galuppo, J. Bauersachs, D. G. Sedding, D. Fraccarollo (Hannover) |
|
(P1400) |
Analysis of CREM-isoforms in the myocardium revealed a new class of cAMP induced isoforms. |
| |
|
B. Fels, D. Kranick, M. D. Seidl, W. Schmitz, F. U. Müller (Münster) |
|
(P1401) |
Hybrid 574: a chemical approach to human cardiac mesenchymal cell reprogramming |
| |
|
F. Spallotta, C. Cencioni, S. Atlante, A. M. Zeiher, C. Gaetano (Frankfurt am Main) |
|
(P1402) |
Is “metabolic intervention” offering additional therapeutic options for the dysfunctional myocardium beyond neurohumoral remodeling? |
| |
|
B. Niemann, L. Li, A. Simm, A. Böning, S. Rohrbach (Gießen, Halle/Saale) |
|
(P1403) |
Thymosin ß4 is cardioprotective in chronic myocardial ischemia even in models with cardiovascular risk factors |
| |
|
A. Howe, S. Straub, W. Husada, S. Lee, C. Lebherz, I. Bock-Marquette, S. Renner, E. Wolf, R. Hinkel, C. Kupatt (München, Aachen, Oberschleißheim; Dallas, US) |